Effect of Chinese Traditional Medicine for Post Revascularization Treatment of Coronary Artery Disease

Summary

The purpose of this study is to built the standard of Chinese Traditional Medicine test for Post percutaneous coronary artery intervention and coronary artery bypass graft，also for acute coronary syndrome，according to the multi-site、random large sample test.

Conditions

• Percutaneous Coronary Artery Intervention
• Coronary Artery Bypass Graft
• Acute Coronary Syndrome

Interventions

DRUG

cipher prescription 1

Drug granules include ginseng,RADIX NOTOGINSENG,prepared RHIZOMA PINELLIAE with alumen radix glyrrhigae calcaren once daily for 180 days

DRUG

cipher prescription 2

Placebo include amidon、bitter principles and diluents bases once daily for 180 days

Sponsors & Collaborators

• Xiyuan Hospital of China Academy of Chinese Medical Sciences

  collaborator OTHER

• Guangdong Provincial People's Hospital

  collaborator OTHER

• China-Japan Friendship Hospital

  collaborator OTHER

• Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region

  collaborator UNKNOWN

• First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

  collaborator OTHER

• Teaching Hospital of Nanjin University of Traditional Chinese Medicine

  collaborator UNKNOWN

• Second People's Hospital, Fujian Province

  collaborator OTHER

• Liaoning University of Traditional Chinese Medicine

  collaborator OTHER

• Guangzhou Overseas Chinese Hospital

  collaborator UNKNOWN

• Beijing Tongren Hospital

  collaborator OTHER

• Shanghai 10th People's Hospital

  collaborator OTHER

• PLA.The Military General Hospital of Beijing

  collaborator UNKNOWN

• The Sixth Affliated Hospital of Jinan University

  collaborator UNKNOWN

• Beijing Anzhen Hospital

  collaborator OTHER

• Gansu Provincial Hospital

  collaborator OTHER

• Shaanxi Provincial People's Hospital

  collaborator OTHER

• First Affiliated Hospital, Sun Yat-Sen University

  collaborator OTHER

• The Fifth Affliated Hospital of Guangxi Medical University

  collaborator UNKNOWN

• Guangzhou University of Chinese Medicine

  lead OTHER

Principal Investigators

• Ruan Xinmin · Guangzhou University of Chinese Medecine

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2006-10-31

Primary Completion

2008-10-31

Completion

2009-06-30